BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16006053)

  • 21. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
    Schabath H; Runz S; Joumaa S; Altevogt P
    J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of CXCR4 in lung cancer metastasis and its possible mechanism].
    Su LP; Zhang JP; Xu HB; Chen J; Wang Y; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1190-4. PubMed ID: 16029594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids?
    Harvey JR; Mellor P; Eldaly H; Lennard TW; Kirby JA; Ali S
    Clin Cancer Res; 2007 Mar; 13(5):1562-70. PubMed ID: 17332302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
    Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB
    Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB.
    Maroni P; Bendinelli P; Matteucci E; Desiderio MA
    Carcinogenesis; 2007 Feb; 28(2):267-79. PubMed ID: 16840440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
    Van Overstraeten-Schlögel N; Beguin Y; Gothot A
    Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
    Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
    Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
    Tamamura H; Hori A; Kanzaki N; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
    FEBS Lett; 2003 Aug; 550(1-3):79-83. PubMed ID: 12935890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.
    Smadja DM; Bièche I; Uzan G; Bompais H; Muller L; Boisson-Vidal C; Vidaud M; Aiach M; Gaussem P
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2321-7. PubMed ID: 16141404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts.
    Moskovits N; Kalinkovich A; Bar J; Lapidot T; Oren M
    Cancer Res; 2006 Nov; 66(22):10671-6. PubMed ID: 17108103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
    Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
    Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR4 expression mediates glioma cell invasiveness.
    Ehtesham M; Winston JA; Kabos P; Thompson RC
    Oncogene; 2006 May; 25(19):2801-6. PubMed ID: 16407848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells.
    Dar A; Goichberg P; Shinder V; Kalinkovich A; Kollet O; Netzer N; Margalit R; Zsak M; Nagler A; Hardan I; Resnick I; Rot A; Lapidot T
    Nat Immunol; 2005 Oct; 6(10):1038-46. PubMed ID: 16170318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of CXCL12 and CXCR4 in breast cancer.
    Luker KE; Luker GD
    Cancer Lett; 2006 Jul; 238(1):30-41. PubMed ID: 16046252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor-kappaB accounts for the repressor effects of high stromal cell-derived factor-1alpha levels on Tac1 expression in nontumorigenic breast cells.
    Corcoran KE; Rameshwar P
    Mol Cancer Res; 2007 Apr; 5(4):373-81. PubMed ID: 17409218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
    Yuecheng Y; Xiaoyan X
    Eur J Cancer Prev; 2007 Oct; 16(5):430-5. PubMed ID: 17923814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
    Sun YX; Fang M; Wang J; Cooper CR; Pienta KJ; Taichman RS
    Prostate; 2007 Jan; 67(1):61-73. PubMed ID: 17034033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications.
    Airoldi I; Raffaghello L; Piovan E; Cocco C; Carlini B; Amadori A; Corrias MV; Pistoia V
    Clin Cancer Res; 2006 Jan; 12(1):77-82. PubMed ID: 16397027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.